Deferasirox 62332-0325-30

Package NDC

62332-0325-30

Manufacturer: Alembic Pharmaceuticals Inc.
Dosage Form: Tablet, For Suspension
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: November 21, 2019
Listing Expires: December 31, 2026
Application: ANDA210060

Need to source Deferasirox? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Deferasirox	250 mg/1

Drug Class

Iron Chelator [EPC]Cytochrome P450 1A2 Inhibitors [MoA]Cytochrome P450 2C8 Inhibitors [MoA]

Selected Package

62332-0325-30Selected

30 TABLET, FOR SUSPENSION in 1 BOTTLE (62332-325-30)